UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000037916
Receipt No. R000043218
Scientific Title A Korea-Japan multicenter joint project on Postoperative Adjuvant treatment for Ampulla of Vater cancer
Date of disclosure of the study information 2019/09/05
Last modified on 2021/10/06 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A Korea-Japan multicenter joint project
on Postoperative Adjuvant treatment for Ampulla of Vater cancer
Acronym A Korea-Japan multicenter joint project
on Postoperative Adjuvant treatment for Ampulla of Vater cancer
Scientific Title A Korea-Japan multicenter joint project
on Postoperative Adjuvant treatment for Ampulla of Vater cancer
Scientific Title:Acronym A Korea-Japan multicenter joint project
on Postoperative Adjuvant treatment for Ampulla of Vater cancer
Region
Japan Asia(except Japan)

Condition
Condition Ampulla of Vater Cancer
Classification by specialty
Surgery in general Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate postoperative adjuvant treatment for ampulla of vater carcinoma
To compare the overall survival rates of ampulla of vater carcinoma according to
postoperative adjuvant therapy.
To compare the disease free survival rates of ampulla of vater carcinoma according to
postoperative adjuvant therapy.
The final goal of this study is to evaluate postoperative adjuvant treatment
for ampulla of vater cancer
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes 3 year & 5 year overall survival
3 year & 5 year disease free survival
Key secondary outcomes Recurrence patterns according to postoperative adjuvant treatment.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
1 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria Patients who underwent operation for ampulla of vater carcinoma and diagnosis
confirmed by histopathology between 2002. 1 and 2015. 12
Patients who underwent completed resection of tumor (included only R0 resection)
Key exclusion criteria Patients without available data in the case report form (CRF)
Patients with combined cancer
30-day mortality case associated with operative complication
Patients with neoadjuvant treatment
Patients with R1/R2 resection of tumor
Target sample size 1090

Research contact person
Name of lead principal investigator
1st name Itaru
Middle name
Last name Endo
Organization Yokohama City University
Division name Department of Gastroenterological Surgery
Zip code 2360004
Address 3-9 Fukuura Kanazawaku Yokohama
TEL 0457872650
Email endoit@yokohama-cu.ac.jp

Public contact
Name of contact person
1st name Yasuhiro
Middle name
Last name Yabushita
Organization Yokohama City University
Division name Department of Gastroenterological Surgery
Zip code 2360004
Address 3-9 Fukuura Kanazawaku Yokohama
TEL 0457872650
Homepage URL
Email yabu23@yokohama-cu.ac.jp

Sponsor
Institute Japanese Society of Hepato-Biliary-Pancreatic Surgery
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor Korean Association of Hepato-Biliary-Pancreatic Surgery
Name of secondary funder(s)

IRB Contact (For public release)
Organization Yokohama City University Ethics Committee
Address 3-9 Fukuura Kanazawaku Yokohama
Tel 0457872800
Email rinri@yokohama-cu.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 09 Month 05 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Main results already published
Date of protocol fixation
2019 Year 04 Month 17 Day
Date of IRB
2019 Year 02 Month 22 Day
Anticipated trial start date
2019 Year 04 Month 17 Day
Last follow-up date
2019 Year 12 Month 31 Day
Date of closure to data entry
2020 Year 10 Month 19 Day
Date trial data considered complete
Date analysis concluded

Other
Other related information Retrospective cohort stud

Management information
Registered date
2019 Year 09 Month 03 Day
Last modified on
2021 Year 10 Month 06 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000043218